HIGHLIGHTED ARTICLES FROM ANNALS OF SURGICAL ONCOLOGY
One-Year Experience of Same-Day Mastectomy and Breast Reconstruction Protocol
August 11, 2022
Specht, M.C., Kelly, B.N., Tomczyk, E. et al. One-Year Experience of Same-Day Mastectomy and Breast Reconstruction Protocol. Ann Surg Oncol 29, 5711–5719 (2022). https://doi.org/10.1245/s10434-022-11859-9
Synopsis: A same-day mastectomy recovery protocol was implemented March 2020 at the authors’ institution. Postoperative recovery course was compared to a historical mastectomy cohort. Median length of stay was reduced from 24.5 hours to 5.5 hours, and overnight admissions decreased by 65.8%.
Drug-Eluting Bead, Irinotecan Therapy of Unresectable Intrahepatic Cholangiocarcinoma (DELTIC) with Concomitant Systemic Gemcitabine and Cisplatin
August 11, 2022
Martin, R.C.G., Simo, K.A., Hansen, P. et al. Drug-Eluting Bead, Irinotecan Therapy of Unresectable Intrahepatic Cholangiocarcinoma (DELTIC) with Concomitant Systemic Gemcitabine and Cisplatin. Ann Surg Oncol 29, 5462–5473 (2022). https://doi.org/10.1245/s10434-022-11932-3
Synopsis: The authors hypothesized that delivering irinotecan in drug-eluting beads via the hepatic artery would reduce systemic exposure while targeting to the location of the intra-hepatic cholangiocarcinoma of the liver. Combination Gem/Cis with DEBIRI is safe, and leads to significant improvement in downsizing to resection, improved progression-free survival, and overall survival.
Listen to the ASO's new podcast, Speaking of SurgOnc®
Speaking of SurgOnc® is a podcast brought to you by the Annals of Surgical Oncology (ASO) and the Society of Surgical Oncology (SSO).
The series is hosted by ASO Deputy Editor Dr. Frederick L. (Rick) Greene, who will expand upon ideas from articles published in the Annals. Once a month, Dr. Greene will interview authors and leading experts in surgical oncology.
Listen to the podcast here.
ASO is the journal of choice of surgical oncologists and cancer multidisciplinary teams worldwide regarding surgical oncology research and education, and benefits surgeons, oncologists, hematologists, radiologists, general practitioners, pathologists, researchers, academicians, and other clinical professionals interested in all aspects of the surgical treatment of cancer. ASO strives to improve the practice environment in which high-quality surgical oncology care is delivered, to enhance the quality of life and survival of the surgical patient with cancer.